Cite
HARVARD Citation
Toh, U. et al. (2020). Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer. Cancer science. 111 (8), pp. 2760-2769. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Toh, U. et al. (2020). Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer. Cancer science. 111 (8), pp. 2760-2769. [Online].